Explore the Potential with AI-Driven Innovation
Our detailed focused library is generated on demand with advanced virtual screening and parameter assessment technology powered by the Receptor.AI drug discovery platform. This method surpasses traditional approaches, delivering compounds of better quality with enhanced activity, selectivity, and safety.
We pick out particular compounds from an extensive virtual database of more than 60 billion molecules. The preparation and shipment of these compounds are facilitated by our associate Reaxense.
The library features a range of promising modulators, each detailed with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Plus, each compound is presented with its ideal docking poses, affinity scores, and activity scores, ensuring a thorough insight.
Our high-tech, dedicated method is applied to construct targeted libraries for enzymes.
Fig. 1. The sreening workflow of Receptor.AI
It includes comprehensive molecular simulations of the catalytic and allosteric binding pockets and the ensemble virtual screening accounting for their conformational mobility. In the case of designing modulators, the structural changes induced by reaction intermediates are taken into account to leverage activity and selectivity.
Our library stands out due to several important features:
partner
Reaxense
upacc
P14384
UPID:
CBPM_HUMAN
Alternative names:
-
Alternative UPACC:
P14384; B2R800; Q9H2K9
Background:
Carboxypeptidase M, encoded by the gene with accession number P14384, is a pivotal enzyme that specifically targets and removes C-terminal basic residues, such as Arginine (Arg) or Lysine (Lys), from peptides and proteins. This enzymatic activity is crucial for modulating the activity of peptide hormones and growth factors at the cellular surface, as well as for the degradation of extracellular proteins localized to the membrane.
Therapeutic significance:
Understanding the role of Carboxypeptidase M could open doors to potential therapeutic strategies. Its unique enzymatic function suggests its involvement in critical regulatory processes, making it a promising target for drug discovery efforts aimed at modulating peptide hormone and growth factor activities for therapeutic purposes.